搜索筛选:
搜索耗时4.5887秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[会议论文] 作者:Xialin Zuo,Ping Wu,Xiaoxia Liu,Li Liu,Qian Xu,Aimin Ji, 来源:2013年广东省药师周大会 年份:2013
Various epidemiologic studies in recent years have indicated that light/moderate alcohol consumers have lower risks of nerve degenerative disease,suggesting that ethanol have neuroprotective effect.Et...
[会议论文] 作者:Li Liu,Xiaoxia Liu,Qian Xu,Ping Wu,Xialin Zuo,Jingjing Zhang,Houliang Deng,Zhuomin Wu,Aimin Ji, 来源:2014年广东省药师周大会 年份:2014
The clinical application of small interference RNA (siRNA) has been restricted by poor intracellular uptake, low serum stability, non-targeting property et al.During last decades, a lot of effort has...
[会议论文] 作者:Houliang Deng,Xialin Zuo,Jingjing Zhang,Xiaoxia Liu,Li Liu,Qian Xu,Zhuomm Wu,Wenshi Li,Aimin Ji, 来源:2014年广东省药师周大会 年份:2014
It is well known that brain is sensitive to ischemia/reperfusion (I/R) induced injury.α-lipoic acid (LA), a free radical scavenger and antioxidant, has protective effects against I/R induced injury.Th...
[会议论文] 作者:Shah Chen,Qian Xu,Aimin Ji,Xiaoxia Liu,Wenfei Gong,Huan Yang,Daofei Luo,Xialin Zuo,Wenshi Li,Ping Wu,, 来源:2014年广东省药师周大会 年份:2014
siRNA targeting the murine VEGFR2 gene was designed and validated for efficient and robust silencing in vitro, and was then delivered by PEI in vivo to investigate the anti-tumor effect on non-small-c...
[会议论文] 作者:Xiaoxia Liu,Wei Wang,Dmitry Samarsky,Li Liu,Qian Xu,Wenqing Zhang,Guangzu Zhu,Ping Wu,Xialin Zuo,Houliang, 来源:2015广东省药师周大会 年份:2014
RNAi technology is taking strong position among the key therapeutic modalities,with dozens of siRNA-based programs entering and successfully progressing through clinical stages of drug development.To...
相关搜索: